Navigation Links
Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
Date:11/9/2012

CRANBURY, N.J., Nov. 9, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2013 financial results on Wednesday, November 14, 2012 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2012, which will include discussion of the results of operations in greater detail and an update on corporate developments.Schedule for the Financial Results Press Release, Conference Call / Webcast

  • Q1 Fiscal Year 2013 Financial Results Press Release

    • 11/14/2012 at 7:30 a.m. ET

     

  • Q1 Fiscal Year 2013 Conference Call-Live
    Domestic Dial-In Number
    International Dial-In Number
    Passcode

    • 11/14/2012 at 11:00 a.m. ET
    1-888-428-9490
    1-719-325-2354

    9649528

     

  • Q1 Fiscal Year 2013 Conference Call-Replay
    Domestic Dial-In Number
    International Dial-In Number
    Passcode

    • 11/14/2012-11/20/2012
    1-888-203-1112
    1-719-457-0820
    9649528

     

  • Webcast Live and Replay Access

    • http://www.palatin.comThe webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts"

    section of Palatin's website at http://www.palatin.com. About Palatin Technologies, Inc.
    Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.


    '/>"/>
    SOURCE Palatin Technologies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1

    Related biology technology :

    1. Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
    2. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
    3. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
    4. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
    5. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
    6. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
    7. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
    8. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
    9. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
    10. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
    11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/18/2013)... 2013 PathoGenetix, Inc. , ... rapid bacterial strain typing, announced today that John ... as Vice President of Engineering. Dr. Luckey will ... RESOLUTION™ Microbial Genotyping System . The fully ... pathogen-specific assay kits, database and software, will be ...
    (Date:6/18/2013)... DC (PRWEB) June 18, 2013 On ... Services (CMS) released a final decision memorandum concluding ... to guide subsequent management of anti-tumor strategy, and ... collection. The National Oncological PET Registry (NOPR) was developed ... the first projects under the Coverage with Evidence Development ...
    (Date:6/17/2013)... MA (PRWEB) June 17, 2013 ... system in March that helps better monitor potentially harmful ... The microAnalyzer V2.0, which was developed by Draper ... Space Station. , Astronauts breathe air that is processed ... to harmful compounds in the air, even in trace ...
    (Date:6/17/2013)... 2013 The Defense Threat Reduction Agency ... at the Waterford in Springfield, Virginia on July 22-25 ... will present technical details on their counter weapons of ... broad range of counter WMD areas including: (1) Science ... Science; (3) Science for Protection; (4) Science to Defeat ...
    Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2
    ... 2007 -, - Tests Delivered Grew 68 Percent Compared to ... - Conference Call Today at ... Health,Inc. (Nasdaq: GHDX ) today reported financial results and business progress,for ... million in the first quarter of 2008,compared to $14.1 million in the ...
    ... Pfizer Enterprise 2.0 expert, to deliver keynote address ... ... Pa., May 6 Simon Revell, Manager of Enterprise,2.0 Technology ... Web 2.0,social software can be leveraged to stimulate the advancement ...
    ... Awards with ,Blue Ladies, a, Masterpiece of a ... CHICAGO, May 6 AbelsonTaylor, long known ... top honors in the medical device category at ... awards ceremony was part of,the DTC National Conference ...
    Cached Biology Technology:Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 9Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 2Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 3AbelsonTaylor Captures DTC Gold 2AbelsonTaylor Captures DTC Gold 3
    (Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
    (Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
    (Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...
    Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
    ... Charlie Kerfoot,s doughnut, and all fingers point to a European ... No one knew about the doughnut in southern Lake Michigan, ... Charles Kerfoot and his research team first saw it in ... their research vessels on any of the shipwreck-studded Great Lakes ...
    ... 17, 2010Colon cancer is the second most common cancer in ... year. It has been known for some time that mutations ... of all sporadic colon cancers. Now researchers at Huntsman Cancer ... featured today in Cell the mechanism by which mutation of ...
    ... We run our modern lives largely by the clock, from ... herald each new workday to the watches and clocks that ... the like. In addition to those ubiquitous timekeepers, ... biological machinery and which help set our circadian rhythms, regulating ...
    Cached Biology News:Death of the 'doughnut' 2Death of the 'doughnut' 3Mechanism behind demethylation pinpointed in APC gene mutants 2Tick tock: Rods help set internal clocks, biologist says 2
    Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
    Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
    Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
    Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
    Biology Products: